Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion type Assertion NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_head.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion description "[We identified individuals with CYP2C9*2 and CYP2C9*3 genotypes (>or=1 variant allele) in the Adenoma Prevention with Celecoxib trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_provenance.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion evidence source_evidence_literature NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_provenance.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion SIO_000772 19233181 NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_provenance.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion wasDerivedFrom befree-2016 NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_provenance.
- NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_assertion wasGeneratedBy ECO_0000203 NP721642.RAEt9ywd5UQJzm-F3JqBhLuNBsZDPyussBbfkUz_fTDGo130_provenance.